“= Question Id: 13907

— Item 19 of 25 = y Mark <I e a i @ al

e
Previous Next Full Screen Tutorial Lab Values

produce seizures in a patient without an underlying seizure disorder.

(Choices B and E) Withdrawal from lithium or quetiapine, when used to treat bipolar disorder,
may be associated with a risk for manic relapse and nonspecific rebound psychiatric
symptoms (eg, anxiety, restlessness). However, withdrawal from these medications would not
explain this patient's symptoms or seizure.

(Choice D) Opioid (eg, oxycodone) withdrawal is characterized by nausea, vomiting, diarrhea,
lacrimation, dilated pupils, and piloerection.

(Choice F) Selective serotonin reuptake inhibitor (eg, sertraline) withdrawal presents with

rebound anxiety/dysphoria, dizziness, headache, and nausea.

Educational objective:
Benzodiazepine withdrawal is characterized by anxiety, tremor, insomnia, and sympathetic
hyperactivity (eg, diaphoresis, palpitations). Severe benzodiazepine withdrawal may also be

accompanied by psychosis, seizures, or death.

References
¢ Benzodiazepine harm: how can it be reduced?

¢ Sedative-hypnotic drug withdrawal syndrome: recognition and treatment.

Block Time Elapse

Tutor

Notes

Calculator

‘4

Reverse Color

GAA)

Text Zoom

63

Settings

End Block
